C-ANCA

C-ANCA

C-ANCA pattern on immunofluorescence microscopy

C-ANCA, or cytoplasmic anti-neutrophil cytoplasmic antibodies, are a type of autoantibody primarily associated with granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis. These antibodies target proteins within the cytoplasm of neutrophils, a type of white blood cell.

Immunofluorescence

C-ANCA is detected using immunofluorescence microscopy, a technique that uses antibodies labeled with fluorescent dyes to visualize the presence of specific antigens in biological samples. In the case of C-ANCA, the immunofluorescence pattern is characterized by a diffuse, granular staining of the cytoplasm of neutrophils, as seen in the accompanying image.

Clinical Significance

C-ANCA is most commonly associated with granulomatosis with polyangiitis, a form of vasculitis that affects small to medium-sized blood vessels. The presence of C-ANCA is a key diagnostic marker for this condition, although it can also be found in other types of vasculitis and autoimmune diseases.

Granulomatosis with Polyangiitis

Granulomatosis with polyangiitis is an autoimmune disease characterized by inflammation of blood vessels, which can lead to damage in various organs, including the kidneys, lungs, and sinuses. Symptoms may include nasal congestion, sinusitis, cough, hemoptysis, and renal impairment. Early diagnosis and treatment are crucial to prevent severe complications.

Pathophysiology

The exact mechanism by which C-ANCA contributes to disease is not fully understood. However, it is believed that these antibodies activate neutrophils, leading to the release of inflammatory mediators and subsequent damage to blood vessel walls. This process results in the characteristic vasculitis seen in affected patients.

Diagnosis and Testing

The detection of C-ANCA is typically performed using indirect immunofluorescence on ethanol-fixed neutrophils. A positive C-ANCA test, in conjunction with clinical findings, supports the diagnosis of granulomatosis with polyangiitis. Additional tests, such as biopsy of affected tissues, may be necessary to confirm the diagnosis.

Treatment

Treatment of conditions associated with C-ANCA, such as granulomatosis with polyangiitis, often involves the use of immunosuppressive drugs like corticosteroids and cyclophosphamide. More recently, biologic agents such as rituximab have been used to target specific components of the immune system.

Related Pages

• Autoantibody
• Granulomatosis with polyangiitis
• Vasculitis
• Immunofluorescence